My research focuses on the design and development of chemical and nanobiotechnological platforms to address pressing biomedical challenges. I have established expertise in DNA detection, nanomaterials synthesis and assembly, protein engineering, biosensing, and drug discovery. Specifically, I have developed DNA-fueled probes for detecting single-base mutations in nucleic acids, constructed DNA-based nanostructures for programmable and targeted drug delivery, and engineered biomaterials capable of precise molecular recognition. In addition, I have advanced aptamer-based biosensing and bioimaging strategies to guide cellular and in vivo therapies. Building on these foundations, my current interests lie in exploring novel platforms, biomaterial assemblies, and biocompatible delivery systems for cancer therapy and molecular imaging. Ultimately, my long-term goal is to bridge molecular design with translational applications, thereby contributing to the development of next-generation diagnostics and therapeutics.